Related Experiment Video
Updated: Oct 22, 2025
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.3K
Punicic Acid Triggers Ferroptotic Cell Death in Carcinoma Cells
Perrine Vermonden1, Matthias Vancoppenolle1, Emeline Dierge1,2
1Louvain Institute of Biomolecular Science and Technology (LIBST), UCLouvain, Croix du Sud 4-5/L7.07.03, B-1348 Louvain-la-Neuve, Belgium.
Nutrients
|August 27, 2021
Summary
Punicic acid (PunA) from pomegranate oil induces cancer cell death via ferroptosis, a process involving lipid peroxidation. Combining PunA with DHA enhances its anti-cancer effects, suggesting PunA as a potential cancer treatment agent.
Area of Science:
- Oncology
- Biochemistry
- Cell Biology
Background:
- Plant-derived conjugated linolenic acids (CLnA) show promise in cancer prevention and therapy.
- Punicic acid (PunA), a CLnA isomer abundant in pomegranate seed oil, exhibits anti-cancer properties, but its mechanism is not fully understood.
- Ferroptosis, a cell death pathway driven by lipid peroxidation, is a potential mechanism for CLnA-induced cytotoxicity.
Purpose of the Study:
- To investigate the cytotoxic effects of punicic acid (PunA) on colorectal and hypopharyngeal carcinoma cells.
- To determine if PunA induces ferroptosis in cancer cells.
- To explore the synergistic effects of PunA in combination with docosahexaenoic acid (DHA).
Main Methods:
- Assessing PunA cytotoxicity on HCT-116 and FaDu cancer cells in monolayer and 3D spheroid cultures.
- Measuring lipid peroxidation levels to confirm ferroptosis induction.
- Evaluating the effect of ferroptosis inhibitors on PunA-induced cell death.
- Testing the combined cytotoxicity of PunA and docosahexaenoic acid (DHA).
Main Results:
- PunA demonstrated significant cytotoxicity against both colorectal and hypopharyngeal carcinoma cell lines.
- PunA treatment led to increased lipid peroxidation, indicative of ferroptosis induction.
- Ferroptosis inhibitors abrogated the cytotoxic effects of PunA.
- Combination therapy with DHA synergistically enhanced PunA's anti-cancer activity.
Conclusions:
- Punicic acid (PunA) effectively induces ferroptosis in carcinoma cells.
- PunA shows potential as a ferroptosis-sensitizing agent for cancer treatment.
- The synergistic effect with DHA suggests combined therapeutic strategies for enhanced cancer prevention and therapy.
Keywords:
acidscarcinoma cellsconjugated linolenicdocosahexaenoic acidferroptosislipid peroxidationpunicic acidspheroidsMore Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.9K
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
15.2K
Related Concept Videos
01:16Necrosis
5.0K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.0K
02:23Abnormal Proliferation
4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
01:30Overview of Cell Death
8.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
8.1K
01:31The Intrinsic Apoptotic Pathway
7.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
01:46Electron Transport Chain: Complex I and II
15.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.4K
01:25Mutagenicity and Carcinogenicity
1.5K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.5K